Mirae Asset Global ETFs Holdings’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36.4K Buy
3,214
+68
+2% +$749 ﹤0.01% 2968
2025
Q4
$25.2K Buy
3,146
+8
+0.3% +$187 ﹤0.01% 3028
2025
Q3
$150K Sell
3,138
-364
-10% -$8.08K ﹤0.01% 2468
2025
Q2
$43.7K Sell
3,502
-156
-4% -$2.25K ﹤0.01% 2905
2025
Q1
$63.7K Buy
3,658
+156
+4% +$4.63K ﹤0.01% 2795
2024
Q4
$133K Buy
3,502
+152
+5% +$7.81K ﹤0.01% 2580
2024
Q3
$112K Buy
+3,350
New +$141K ﹤0.01% 2665

Other funds holding KRRO

Mirae Asset Global ETFs Holdings's KRRO Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Korro Bio (KRRO) stake by 2.2% in Q1 2026, buying an estimated $749 and bringing the position to 3,214 shares worth $36.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2968.

Mirae Asset Global ETFs Holdings first reported a position in KRRO in Q3 2024 and has held it in 7 quarters since. The position peaked at $150K in Q3 2025. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 3,214 shares of Korro Bio worth $36.4K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 68 Korro Bio shares in Q1 2026, an estimated $749.
  • Korro Bio made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2968 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Korro Bio in Q3 2024 and has held it in 7 quarters since.
  • Mirae Asset Global ETFs Holdings's Korro Bio position peaked at $150K in Q3 2025.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.